These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20809175

  • 1. Invasive IPMN and MCN: same organ, different outcomes?
    Kargozaran H, Vu V, Ray P, Bagaria S, Steen S, Ye X, Gagandeep S.
    Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
    [Abstract] [Full Text] [Related]

  • 2. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.
    Hepatogastroenterology; 2010 Feb; 57(99-100):635-9. PubMed ID: 20698241
    [Abstract] [Full Text] [Related]

  • 3. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
    Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.
    Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [Abstract] [Full Text] [Related]

  • 6. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.
    J Surg Oncol; 2009 Jul 01; 100(1):13-8. PubMed ID: 19384908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.
    Arch Surg; 2008 Jul 01; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [Abstract] [Full Text] [Related]

  • 10. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N.
    Pancreas; 2006 Apr 01; 32(3):281-7. PubMed ID: 16628084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M.
    Ann Surg Oncol; 2006 Jul 01; 13(7):955-60. PubMed ID: 16788757
    [Abstract] [Full Text] [Related]

  • 15. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Ann Surg Oncol; 2007 Nov 01; 14(11):3174-80. PubMed ID: 17694416
    [Abstract] [Full Text] [Related]

  • 16. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A, Kodera Y.
    Ann Surg Oncol; 2014 Jul 01; 21(7):2444-52. PubMed ID: 24562937
    [Abstract] [Full Text] [Related]

  • 17. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD, Melstrom LG, Bentrem DJ, Ujiki MB, Wayne JD, Strouch M, Bell RH, Rao SM, Talamonti MS.
    Surgery; 2007 Oct 01; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [Abstract] [Full Text] [Related]

  • 18. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y, Ohuchida K, Nakata K, Ohtsuka T, Aishima S, Takahata S, Nakamura M, Mizumoto K, Tanaka M.
    Surgery; 2010 Jun 01; 147(6):812-7. PubMed ID: 20060146
    [Abstract] [Full Text] [Related]

  • 19. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.
    Surgery; 2015 Oct 01; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [Abstract] [Full Text] [Related]

  • 20. Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas.
    Kuroki T, Adachi T, Ono S, Tanaka T, Kitasato A, Takatsuki M, Eguchi S.
    Hepatogastroenterology; 2012 Oct 01; 59(120):2631-4. PubMed ID: 22534541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.